The council strives to promote basic, translational and clinical research in cardiovascular physiology and pathology. Annually AHA asks all of its Councils and science groups what in their estimation have been the most important advances in their respective fields within the past year. We have pulled out of all of those suggestions, the ones that came from or are relevant to our community. These advances and their potential to impact atherosclerosis, thrombosis, vascular biology and the patient are listed in the table below.
Edward F. Plow, Ph.D., FAHA
Chair, Council on Arteriosclerosis,
Thrombosis and Vascular Biology (ATVB)
|
|
Nigel Mackman, Ph.D., FAHA
Vice-Chair, Council on Arteriosclerosis,
Thrombosis and Vascular Biology (ATVB)
|
more...
Most Recent Comments